Moody Aldrich Partners LLC Beam Therapeutics Inc. Transaction History

Moody Aldrich Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$29.86 - $62.36 $776,210 - $1.62 Million	-25,995 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$53.73 - $82.16 $102,140 - $156,186	1,901 Added 7.89%	25,995 $1.49 Million
Q4 2021 Feb 02, 2022	SELL	$68.02 - $99.06 $308,606 - $449,435	-4,537 Reduced 15.85%	24,094 $1.92 Million
Q3 2021 Oct 29, 2021	BUY	$84.37 - $133.6 $338,745 - $536,404	4,015 Added 16.31%	28,631 $2.49 Million
Q2 2021 Aug 04, 2021	BUY	$64.12 - $128.71 $1.58 Million - $3.17 Million	24,616 New	24,616 $3.17 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.